Skip to main content
. 2020 Jun 30;27(9):2269–2279. doi: 10.1016/j.sjbs.2020.06.044

Fig. 8.

Fig. 8

Anti-carbapenemase activity of HPLC purified EO fraction treated and untreated CR K. pneumoniae by invitro Carba NP test (a) and quantification of carbapenemase inhibition percentages at various concentration of HPLC purified EO fraction (b) by colorimetric analysis.